FERRING PHARMACEUTICALS, INC.
FERRING PHARMACEUTICALS, INC. filed a Q2 report for FERRING PHARMACEUTICALS, INC. on July 18, 2025.
Lobbying for FERRING PHARMACEUTICALS, INC.
Issues related to fertility treatment and coverage (no bill); issues related to federal employee health care coverage (no bill) issues related to veteran health care coverage (no bill); issues related to military health care coverage (no bill); issues related to Medicare physician fee schedule and Orphan Cures (To provide for reconciliation pursuant to title II of H. Con. Res. 14 (H.R. 1 / no Senate bill number)).
Issues related to establishing a tax credit for fertility treatments (IVF Access and Affordability Act, H.R. 1878 / no Senate bill); issues related to taxation of foreign businesses (To provide for reconciliation pursuant to title II of H. Con. Res. 14 (H.R. 1 / no Senate bill number)).